The Duke Margolis Center for Health Policy, in collaboration with the FDA, is convening a virtual two-day workshop May 24-25 from 12pm ET – 4pm ET, titled “Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More.” This workshop will be of key relevance to a wide array of faculty, staff, and students working in basic, translational, and clinical sciences that support the development of therapeutics.

Registration is required.

For any questions about the workshop, please feel free to reach out to Erin Soule or Nancy Allen Lapointe.